Никола Тесла
Iron
- Joined
- Apr 7, 2026
- Posts
- 43
- Reputation
- 10
Hey, looking for input on my situation before an endocrinology appointment.
Background: I’m 18 legally but have a bone age of ~14-15 (confirmed by wrist X-ray). My GP referred me to an endo after seeing the X-ray results. I’ve been on isotretinoin (5 months at 30mg, 3-month break, then 1 month at 40mg, currently finishing 2 months at 50mg) and I’m worried accutane may have accelerated growth plate closure.
Question 1 – Does the referral itself mean anything?
My GP wrote to the endo himself after seeing the bone age gap. Does that kind of referral already signal that there’s a real case here, or is it just routine? I’m wondering if showing up with a 3-4 year bone age delay already puts me in a position where treatment is likely to be considered seriously.
Question 2 – MK-677 before/during the appointment
A friend is considering running a MK-677 cycle but would want to stop before the endo appointment. The concern is that MK-677 chronically elevates IGF-1 — would that still show up on bloodwork even after stopping, and would elevated IGF-1 actually hurt the case for getting prescribed rhGH?
Question 3 – Low-dose AI
Same scenario but with a mild aromatase inhibitor. Would suppressed estradiol raise red flags on a hormonal panel, and could it complicate the endo’s interpretation of the case?
Question 4 – What can I do in the next 2 months to maximize chances of getting prescribed rhGH?
MANY THANKS IN ADVANCE.
Background: I’m 18 legally but have a bone age of ~14-15 (confirmed by wrist X-ray). My GP referred me to an endo after seeing the X-ray results. I’ve been on isotretinoin (5 months at 30mg, 3-month break, then 1 month at 40mg, currently finishing 2 months at 50mg) and I’m worried accutane may have accelerated growth plate closure.
Question 1 – Does the referral itself mean anything?
My GP wrote to the endo himself after seeing the bone age gap. Does that kind of referral already signal that there’s a real case here, or is it just routine? I’m wondering if showing up with a 3-4 year bone age delay already puts me in a position where treatment is likely to be considered seriously.
Question 2 – MK-677 before/during the appointment
A friend is considering running a MK-677 cycle but would want to stop before the endo appointment. The concern is that MK-677 chronically elevates IGF-1 — would that still show up on bloodwork even after stopping, and would elevated IGF-1 actually hurt the case for getting prescribed rhGH?
Question 3 – Low-dose AI
Same scenario but with a mild aromatase inhibitor. Would suppressed estradiol raise red flags on a hormonal panel, and could it complicate the endo’s interpretation of the case?
Question 4 – What can I do in the next 2 months to maximize chances of getting prescribed rhGH?
MANY THANKS IN ADVANCE.
